REGULATED PRESS RELEASE published on 06/26/2024 at 07:01, 2 months 22 days ago bioMérieux obtient l’autorisation spéciale 510(k) et la dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini bioMérieux obtient l’autorisation spéciale 510(k) et la dérogation CLIA pour son test BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel Mini BioMérieux Diagnostic In Vitro BIOFIRE SPOTFIRE Dérogation CLIA Autorisation Spéciale 510(k)
BRIEF published on 06/21/2024 at 08:40, 2 months 27 days ago BioMérieux obtient l’autorisation 510(k) de la FDA américaine pour son système d’antibiogramme VITEK® REVEAL™ FDA BioMérieux Sepsis VITEK® REVEAL™ Antibiogramme
BRIEF published on 06/21/2024 at 08:40, 2 months 27 days ago BioMérieux Receives US FDA 510(k) Clearance for VITEK® REVEAL™ AST System BioMérieux Antimicrobial Resistance FDA Clearance Sepsis VITEK® REVEAL™
REGULATED PRESS RELEASE published on 06/21/2024 at 08:35, 2 months 27 days ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour son système d’antibiogramme VITEK® REVEAL™ bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour son système d’antibiogramme VITEK® REVEAL™. Une avancée majeure pour le diagnostic des sepsis et la lutte contre l'antibiorésistance FDA BioMérieux Diagnostic In Vitro Autorisation 510(k) Antibiogramme VITEK REVEAL
REGULATED PRESS RELEASE published on 06/21/2024 at 08:35, 2 months 27 days ago bioMérieux receives US FDA 510(k) clearance for its AST System VITEK® REVEAL™ bioMérieux's VITEK® REVEAL™ AST System receives FDA 510(k) clearance, enabling rapid antimicrobial susceptibility testing from positive blood cultures BioMérieux FDA 510(k) Clearance Antimicrobial Susceptibility Testing VITEK® REVEAL™ AST System
BRIEF published on 06/05/2024 at 11:27, 3 months 13 days ago Déclaration de bioMérieux sur le capital social et les droits de vote en mai 2024 Droits De Vote Capital Social BioMérieux Actions Mai 2024
BRIEF published on 06/05/2024 at 11:27, 3 months 13 days ago BioMérieux declaration on share capital and voting rights in May 2024 Share Capital Voting Rights BioMérieux Actions May 2024
REGULATED PRESS RELEASE published on 06/05/2024 at 11:22, 3 months 13 days ago Mai 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant Communiqué de presse sur les droits de vote et actions de bioMérieux, société au capital de 12 029 370 euros. Informations mensuelles conformes à la réglementation financière en vigueur Droits De Vote BioMérieux Actions Informations Mensuelles Règlement Financier
BRIEF published on 05/28/2024 at 18:06, 3 months 21 days ago BioMérieux Receives FDA 510(k) Clearance for VIDAS® TBI Test BioMérieux FDA Clearance VIDAS TBI Mild Traumatic Brain Injury CT Scans
BRIEF published on 05/28/2024 at 18:06, 3 months 21 days ago BioMérieux obtient l'agrément 510(k) de la FDA pour le test VIDAS® TBI FDA BioMérieux Diagnostic VIDAS® TBI Traumatisme Crânien
Published on 09/18/2024 at 23:10, 4 hours 1 minute ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 4 hours 11 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 5 hours 56 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 6 hours 11 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 10 hours 41 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 8 hours ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 8 hours 25 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 8 hours 39 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 8 hours 57 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 9 hours 49 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 8 hours 25 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 8 hours 25 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 9 hours 31 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.